Locus coeruleus modulates thalamic nociceptive responses via adrenoceptors

Brain Research

Volumn 784, Issue 1-2, 1998, Pages 116-122

  Zhang, Ce ^a   Guo, Youg Qiang ^a   Qiao, Jian Tian ^a,b   Dafny, Nachum ^b  

^a Shanxi Medical College   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Intracerebroventricular injection; Intrathecal injection; Locus coeruleus; Nociceptive modulation; Parafascicular neuron; Prazosin; Yohimbine

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; NORADRENALIN; PRAZOSIN; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; FACILITATION; FEMALE; LOCUS CERULEUS; MALE; NEUROTRANSMISSION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; FEMALE; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; LOCUS COERULEUS; MALE; NOCICEPTORS; NOREPINEPHRINE; PRAZOSIN; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; STEREOTAXIC TECHNIQUES; THALAMUS; YOHIMBINE;

EID: 0032536564     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01197-9     Document Type: Article

References (27)

1. Besson J.M., Chaouch A. Peripheral and spinal mechanism of nociception. Physiol. Rev. 67:1987;67-186.
2. 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol. Pharmacol. 42:1992;1-5.
3. Bylund D.B., Ray-Prenger C., Murphy T.J. Alpha-2A and alpha-2B adrenergic receptor subtypes. Antagonist binding in tissues and cell lines containing only one subtype. J. Pharmacol. Exp. Ther. 245:1988;600-607.
4. Dahlström A., Fuxe K. Evidence for the existence of monoamine containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurons. Acta Physiol. Scand. 62(Suppl. 232):1964;1-55.
5. Danzebrink R.M., Gebhart G.F. Antinociceptive effects of intrathecal adrenoceptor agonists in a rat model of visceral nociception. J. Pharmacol. Exp. Ther. 233:1990;698-705.
6. H.L. Fields, A.I. Basbaum, Central nervous system mechanisms of pain modulation. In: Textbook of Pain, B.D. Wall, R. Melzack (Eds.), 1994, Churchill Livingstone, pp. 234-257.
7. Howe J.R., Wang J., Yaksh T.L. Selective antagonisms of the antinociceptive effect of intrathecally applied alpha adrenergic agonists by intrathecal prazosin and intrathecal yohimbine. J. Pharmacol. Exp. Ther. 224:1983;552-558.
8. Jones S.L. Descending noradrenergic influences on pain. Prog. Brain Res. 88:1991;381-394.
9. Jones S.L., Gebhart G.F. Quantitative characterization of coeruleospinal inhibition of nociceptive transmission in the rat. J. Neurophysiol. 56:1986;1397-1410.
10. 2-adrenceptors. Brain Res. 364:1986;315-330.
11. Kuraishi Y., Hirota N., Sato Y., Kaneko S., Satoh M., Takagi H. Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn. Brain Res. 359:1985;177-182.
12. Nagasaka H., Yaksh T.L. Pharmacology of intrathecal adrenergic agonists. Cardiovascular and nociceptive reflexes in halothane anesthetized rats. Anesthesiology. 73:1990;198-1207.
13. G. Paxinos, C. Watson, The Rat Brain: In Stereotaxic Coordinates, Academic Press, New York, 1982.
14. Pertovaara A., Bravo R., Herdegen T. Induction and suppression of immediate-early genes in the rat brain by a selective alphentolaminea-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation. Neuroscience. 54:1993;117-126.
15. Price H.K., Fibiger H.C. Ascending catecholamine systems and morphine analgesia. Brain Res. 99:1975;189-239.
16. Qiao J.T., Dafny N. Dorsal raphe stimulation modulates nociceptive responses in the thalamus parafascicular neurons via an ascending pathway: further study on ascending pain modulation pathways. Pain. 34:1988;65-74.
17. 2-Adrenoceptor agonists and antagonists. Neurotransmissions. 4:1990;1-5.
18. Sawynok J., Reid A. Lesions to ascending noradrenergic and serotonergic pathways modify antinociception produced by intracerebroventricular administration of morphine. Neuropharmacology. 28:1989;141-147.
19. Takano Y., Yaksh T.L. Relative efficacy of spinal alphentolamine-2 agonists, dexmedetomidine, clonidine and ST-91 determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist. J. Pharmacol. Exp. Ther. 258:1991;438-446.
20. Takano Y., Yaksh T.L. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats. J. Pharmacol. Exp. Ther. 261:1992;764-772.
21. 2-agonists. Peptides. 14:1993;371-378.
22. 2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurons. Brain Res. 334:1985;243-254.
23. Weinshank R.L., Zyombick J.M., Macchi M., Adhan N., Lichtblau H., Branchek T.A., Itartic P.R. Cloning, expression and pharmacological characterization of a human alpha-2B adrenergic receptor. Mol. Pharmacol. 38:1990;681-688.
24. West W.L., Yeomans D.C., Proudfit H.K. The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats. Brain Res. 626:1993;127-135.
25. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036.
26. Zhang C., Yang S.W., Guo Y.Q., Qiao J.T., Dafny N. Locus coeruleus stimulation modulates the nociceptive responses in parafascicular neurons: an analysis of descending and ascending pathways. Brain Res. Bull. 42:1997;273-278.
27. Zhang R.X., Mi Z.P., Xie Y.F., Qiao J.T. Serotonergic, noradenergic and galaninergic projections to the nucleus parafascicularis. Neuroreport. 3:1992;135-138.